Jennifer Sharpe Potter
Affiliation: University of Texas Health Science Center
- Characteristics of first-time alcohol treatment seekers: the COMBINE StudyJoseph S Locastro
Department of Psychiatry, Boston University School of Medicine, Boston, Massachusetts, and Veterans Affairs Boston Healthcare System, Boston, Massachusetts, USA
J Stud Alcohol Drugs 69:885-95. 2008....
- Pain and continued opioid use in individuals receiving buprenorphine-naloxone for opioid detoxification: secondary analyses from the Clinical Trials NetworkJennifer Sharpe Potter
Division of Alcohol and Drug Abuse, Department of Psychiatry, University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA
J Subst Abuse Treat 38:S80-6. 2010..These findings lend further support for continued research on pain among patients with opioid dependence...
- Buprenorphine/Naloxone and Methadone Maintenance Treatment Outcomes for Opioid Analgesic, Heroin, and Combined Users: Findings From Starting Treatment With Agonist Replacement Therapies (START)Jennifer S Potter
The University of Texas Health Science Center at San Antonio, San Antonio, Texas
J Stud Alcohol Drugs 74:605-13. 2013..These results have particular clinical interest, as there is no evidence of superiority of BUP over methadone for treating OA users versus heroin users. (J. Stud. Alcohol Drugs, 74, 605-613, 2013)...
- Site selection in community-based clinical trials for substance use disorders: strategies for effective site selectionJennifer Sharpe Potter
Division of Alcohol and Drug Abuse, Department of Psychiatry, School of Medicine, University of Texas Health Science Center, San Antonio, 78232, USA
Am J Drug Alcohol Abuse 37:400-7. 2011..Selecting high-quality sites to participate is critical to recruitment, retention, and overall trial performance when conducting multi-site, community-based clinical trials of treatments for substance use disorders...
- Adjunctive counseling during brief and extended buprenorphine-naloxone treatment for prescription opioid dependence: a 2-phase randomized controlled trialRoger D Weiss
Division of Alcohol and Drug Abuse, McLean Hospital, Belmont, MA 02478, USA
Arch Gen Psychiatry 68:1238-46. 2011..No randomized trials have examined treatments for prescription opioid dependence, despite its increasing prevalence...
- Patient characteristics associated with buprenorphine/naloxone treatment outcome for prescription opioid dependence: Results from a multisite studyJessica A Dreifuss
Division of Alcohol and Drug Abuse, McLean Hospital, Belmont, MA 02478, USA Department of Psychiatry, Harvard Medical School, Boston, MA 02115, USA Electronic address
Drug Alcohol Depend 131:112-8. 2013..Prescription opioid dependence is a growing problem, but little research exists on its treatment, including patient characteristics that predict treatment outcome...
- Extended vs short-term buprenorphine-naloxone for treatment of opioid-addicted youth: a randomized trialGeorge E Woody
Department of Psychiatry, Treatment Research Institute, University of Pennsylvania, 150 S Independence Mall W, Ste 600, Philadelphia, PA 19106, USA
JAMA 300:2003-11. 2008..The usual treatment for opioid-addicted youth is detoxification and counseling. Extended medication-assisted therapy may be more helpful...
- Impulsivity but not sensation seeking is associated with opioid analgesic misuse risk in patients with chronic painElise N Marino
The University of Texas Health Science Center at San Antonio, 7526 Louis Pasteur, San Antonio, TX 78229, USA
Addict Behav 38:2154-7. 2013..As such, these findings suggest that additional exploration of this potential risk factor is warranted...
- Gender differences in a clinical trial for prescription opioid dependenceR Kathryn McHugh
Division of Alcohol and Drug Abuse, McLean Hospital, Belmont MA 02478, USA
J Subst Abuse Treat 45:38-43. 2013..Thus, despite the presence of pre-treatment gender differences in this population, once the study treatment was initiated, women and men exhibited similar opioid use outcomes...
- Determining the primary endpoint for a stimulant abuse trial: lessons learned from STRIDE (CTN 0037)Madhukar H Trivedi
Department of Psychiatry, University of Texas Southwestern Medical Center at Dallas, 75390 9119, USA
Am J Drug Alcohol Abuse 37:339-49. 2011..Abstinence is the most desirable treatment outcome although a wide variety of other endpoints have been used...
- Chronic Pain Perspectives: How to avoid opioid misuseJennifer Sharpe Potter
The University of Texas Health Science Center at San Antonio, TX, USA
J Fam Pract 62:S2-7. 2013..These practical strategies will help you to identify and monitor the risk of opioid analgesic misuse...